These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15763944)
1. Angiopoietin-1 inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating fas expression and via the PI3K/Akt pathway. Yin D; Li C; Kao RL; Ha T; Krishnaswamy G; Fitzgerald M; Stuart CA Endothelium; 2004; 11(5-6):247-52. PubMed ID: 15763944 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Harfouche R; Hasséssian HM; Guo Y; Faivre V; Srikant CB; Yancopoulos GD; Hussain SN Microvasc Res; 2002 Jul; 64(1):135-47. PubMed ID: 12074640 [TBL] [Abstract][Full Text] [Related]
3. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Wang Z; Jiang C; Ganther H; Lü J Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751 [TBL] [Abstract][Full Text] [Related]
4. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Secchiero P; Gonelli A; Carnevale E; Milani D; Pandolfi A; Zella D; Zauli G Circulation; 2003 May; 107(17):2250-6. PubMed ID: 12668516 [TBL] [Abstract][Full Text] [Related]
5. RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Kim HH; Shin HS; Kwak HJ; Ahn KY; Kim JH; Lee HJ; Lee MS; Lee ZH; Koh GY FASEB J; 2003 Nov; 17(14):2163-5. PubMed ID: 14500543 [TBL] [Abstract][Full Text] [Related]
6. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200 [TBL] [Abstract][Full Text] [Related]
9. MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage. Bild AH; Mendoza FJ; Gibson EM; Huang M; Villanueva J; Garrington TP; Jove R; Johnson GL; Gibson SB Oncogene; 2002 Sep; 21(43):6649-56. PubMed ID: 12242663 [TBL] [Abstract][Full Text] [Related]
10. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes. Moriyama H; Yonehara S Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Schulze-Bergkamen H; Brenner D; Krueger A; Suess D; Fas SC; Frey CR; Dax A; Zink D; Büchler P; Müller M; Krammer PH Hepatology; 2004 Mar; 39(3):645-54. PubMed ID: 14999683 [TBL] [Abstract][Full Text] [Related]
12. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184 [TBL] [Abstract][Full Text] [Related]
13. A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells. Bak Y; Kim H; Kang JW; Lee DH; Kim MS; Park YS; Kim JH; Jung KY; Lim Y; Hong J; Yoon DY J Agric Food Chem; 2011 Sep; 59(18):10286-97. PubMed ID: 21877710 [TBL] [Abstract][Full Text] [Related]
14. Urotensin II inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating ATF expression and via the ERK and Akt pathway. Chen YL; Tsai YT; Lee CY; Lee CH; Chen CY; Liu CM; Chen JJ; Loh SH; Tsai CS PLoS One; 2014; 9(9):e106812. PubMed ID: 25268131 [TBL] [Abstract][Full Text] [Related]
15. FasL/Fas pathway is involved in dengue virus induced apoptosis of the vascular endothelial cells. Liao H; Xu J; Huang J J Med Virol; 2010 Aug; 82(8):1392-9. PubMed ID: 20572077 [TBL] [Abstract][Full Text] [Related]
16. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825 [TBL] [Abstract][Full Text] [Related]
17. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo. Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078 [TBL] [Abstract][Full Text] [Related]